Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19 (2) , 109-115
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
- Genentech
- Celgene
- Merck
- TG Therapeutics
- Bristol-Myers Squibb
- Janssen Research and Development
This publication has 29 references indexed in Scilit:
- Therapeutic options in relapsed or refractory peripheral T-cell lymphomaCancer Treatment Reviews, 2014
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01Journal of Clinical Oncology, 2012
- Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexaroteneLeukemia & Lymphoma, 2011
- Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL StudyJournal of Clinical Oncology, 2011
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study GroupBlood, 2010
- Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95British Journal of Haematology, 2010
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008
- Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationLeukemia, 2006
- Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphomaCancer, 2005
- High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceAnnals of Oncology, 2003